Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
I tested positive for Covid; I tested positive for Covid; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "lung cancer" (ongoing), notes: since patient had lung cancer. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization completed, Manufacture Unknown, Lot: Unknown), for COVID-19 Immunization; Covid-19 vaccine (DOSE NUMBER UNKNOWN (BOOSTER), Manufacture Unknown, Lot: Unknown), for COVID-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 19Mar2025, outcome "unknown" and all described as "I tested positive for Covid". The event "i tested positive for covid" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (19Mar2025) Positive. Clinical course: Wednesday (19Mar2025) patient tested positive for Covid for the first time. Patient had all the Covid booster shots. Patient's doctor prescribed Paxlovid and when patient's husband picked it up we had to pay dollar 735 out of pocket. That was half of patient's insurance check for the whole month. Patient felt the need to take it since patient had lung cancer but patient would never buy a Pfizer product again. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
Lung cancer (since patient had lung cancer)
Test Date: 20250319; Test Name: Covid; Test Result: Positive